1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
FY26 Kidney Cancer Research Program Idea Development Award is sponsored by Congressionally Directed Medical Research Programs (CDMRP). This award supports high-impact research ideas that advance the understanding of kidney cancer and have the potential to improve patient care and outcomes.
Projects must present a well-formulated, testable hypothesis supported by a strong scientific rationale, preliminary data, and a clearly developed research approach.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Applicants may use either a single Principal Investigator or a Partnering PI model that brings together two investigators with complementary expertise. Eligibility depends on the individual CDMRP announcement, but generally open to research institutions, universities, and for-profit businesses. Confirm the full requirements in the official notice before applying.
The current listing shows up to $900,000 total costs over 3 years ($1.2M for the Partnering PI Option). Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was September 14, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
FY26 Kidney Cancer Research Program Idea Development Award is funded by Congressionally Directed Medical Research Programs (CDMRP). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
US CDMRP – Traumatic Brain Injury and Psychological Health Research Program is sponsored by Congressionally Directed Medical Research Programs (CDMRP). This program bridges the gap between research, practice, and policy by building a knowledge base on how to deploy interventions and clinical practices/guidelines and policies to targeted populations at the appropriate time at the point of need.
Breast Cancer Research Program (BCRP) Transformative Breast Cancer Consortium Award is sponsored by Congressionally Directed Medical Research Programs (CDMRP). Supports synergistic, highly integrated, multidisciplinary, and multi-institutional consortia to make a transformative impact in breast cancer. Applications must address at least one of the FY26 BCRP overarching challenges. This mechanism allows for up to five Principal Investigators (PIs) and must include at least one breast cancer consumer advocate per project team. A required pre-application (Letter of Intent) was due June 12, 2026, and full applications will only be accepted if an invitation was received or a Letter of Intent was submitted by the pre-application due date.
The Congressionally Directed Medical Research Programs just released $1.27 billion across 34 programs. Universities, nonprofits, and small businesses are all eligible.
Read articleCDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article